Clinical trials - Press Releases

Date	Title	Company
15-Jun-2023	The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research	The Department of Health – Abu Dhabi
15-Jun-2023	Innova Care Concepts Evolves the World’s Most Innovative Bariatric Care Bed to Enhance Patient Care for Medical Professionals	Innova Care Concepts
15-Jun-2023	SCTbio and Cyto-care collaborate to improve cell therapy cryopreservation and logistics capabilities in Europe	SCTbio
15-Jun-2023	REAL-WORLD RESULTS DEMONSTRATE HIGH RESPONSE RATE AND DURABLE REMISSION WITH KITE CAR T-CELL THERAPIES FOR R/R MCL AND FL AT EHA 2023	Kite, a Gilead Company
15-Jun-2023	Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency	Takeda
15-Jun-2023	The journey from science to health: Clasado puts prebiotic research in the spotlight at IPC and ISAPP	Clasado Biosciences
14-Jun-2023	Enterome's new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma	Enterome
12-Jun-2023	Pioneering clinical trial service launched at PHTA	University of Birmingham
12-Jun-2023	ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress	ImmunoGen
12-Jun-2023	ONDEXXYA▼(ANDEXANET ALFA) PHASE IV TRIAL STOPPED EARLY AFTER ACHIEVING PRE-SPECIFIED CRITERIA ON HAEMOSTATIC EFFICACY VERSUS USUAL CARE	AstraZeneca
09-Jun-2023	Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma	Menarini Group
08-Jun-2023	AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology	AARDEX
07-Jun-2023	Amolyt Pharma to Host Hybrid Key Opinion Leader Event on Eneboparatide, a PTHR1 Agonist Entering Phase 3 for the Treatment of Hypoparathyroidism, in Chicago on June 16, 2023	Amolyt Pharma
07-Jun-2023	Connecta Therapeutics starts clinical trials for its Fragile X syndrome drug	Connecta Therapeutics
07-Jun-2023	Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden	Mural Health
06-Jun-2023	Phastar Statistics Manager Wins Prestigious DIA Award	Phastar
06-Jun-2023	Veeva Business Consulting Expands with New R&D Services	Veeva Systems
02-Jun-2023	Cytovation raises $8 million in Series A extension financing round for clinical advancement of CyPep-1, a first-in-class targeted tumor membrane immunotherapy	Cytovation ASA
31-May-2023	Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral adrenoleukodystrophy	Minoryx Therapeutics
31-May-2023	Enterome announces sustained positive clinical outcomes with EO2401, its lead OncoMimics™ immunotherapy, in combination therapy in Glioblastoma at ASCO	Enterome